152 related articles for article (PubMed ID: 37848987)
1. Upregulation of BMP1 through ncRNAs correlates with adverse outcomes and immune infiltration in clear cell renal cell carcinoma.
Gong M; Feng S; Zhou D; Luo J; Lin T; Qiu S; Yuan R; Dong W
Eur J Med Res; 2023 Oct; 28(1):440. PubMed ID: 37848987
[TBL] [Abstract][Full Text] [Related]
2.
Situ Y; Zhang J; Liao W; Liang Q; Lu L; Xu Q; Chen J; Lu X; Cui Y; Shao Z; Deng L
Front Biosci (Landmark Ed); 2023 Sep; 28(9):196. PubMed ID: 37796681
[TBL] [Abstract][Full Text] [Related]
3. A novel lncRNA-miRNA-mRNA competing endogenous RNA regulatory network in lung adenocarcinoma and kidney renal papillary cell carcinoma.
Zhou Q; Li D; Zheng H; He Z; Qian F; Wu X; Yin Z; Bao PT; Jin M
Thorac Cancer; 2021 Oct; 12(19):2526-2536. PubMed ID: 34453499
[TBL] [Abstract][Full Text] [Related]
4. Activating transcription factor 3 is a new biomarker correlation with renal clear cell carcinoma progression.
Yang Z; Hou Y; Li J; Xu D; Yang Z; Wang X
Int J Immunopathol Pharmacol; 2024; 38():3946320241227320. PubMed ID: 38248871
[No Abstract] [Full Text] [Related]
5. Overexpression of BMP1 reflects poor prognosis in clear cell renal cell carcinoma.
Xiao W; Wang X; Wang T; Xing J
Cancer Gene Ther; 2020 May; 27(5):330-340. PubMed ID: 31155610
[TBL] [Abstract][Full Text] [Related]
6. Potential upstream lncRNA-miRNA-mRNA regulatory network of the ferroptosis-related gene
Xu F; Ji S; Yang L; Li Y; Shen P
Transl Androl Urol; 2023 Jan; 12(1):33-57. PubMed ID: 36760866
[TBL] [Abstract][Full Text] [Related]
7. System analysis of
Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z
Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494
[TBL] [Abstract][Full Text] [Related]
8. Prognosis and biological function of SGOL1 in clear cell renal cell carcinoma: a multiomics analysis.
Yang Z; Jiang Y; Wang L; Yu B; Cai H; Fan J; Zhang M
BMC Med Genomics; 2024 Feb; 17(1):60. PubMed ID: 38383432
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of long noncoding RNA PVT1 predicts unfavorable prognosis in patients with clear cell renal cell carcinoma.
Bao X; Duan J; Yan Y; Ma X; Zhang Y; Wang H; Ni D; Wu S; Peng C; Fan Y; Gao Y; Li X; Chen J; Du Q; Zhang F; Zhang X
Cancer Biomark; 2017 Dec; 21(1):55-63. PubMed ID: 29081406
[TBL] [Abstract][Full Text] [Related]
10. DARS-AS1 promotes clear cell renal cell carcinoma by sequestering miR-194-5p to up-regulate DARS.
Jiao M; Guo H; Chen Y; Li L; Zhang L
Biomed Pharmacother; 2020 Aug; 128():110323. PubMed ID: 32526457
[TBL] [Abstract][Full Text] [Related]
11. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of ceRNA networks to determine genes related to prognosis, overall survival, and immune infiltration in clear cell renal carcinoma.
Chalbatani GM; Momeni SA; Mohammadi Hadloo MH; Karimi Z; Hadizadeh M; Jalali SA; Miri SR; Memari F; Hamblin MR
Comput Biol Med; 2022 Feb; 141():105043. PubMed ID: 34839901
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA lung cancer associated transcript 1 promotes proliferation and invasion of clear cell renal cell carcinoma cells by negatively regulating miR-495-3p.
Wang LN; Zhu XQ; Song XS; Xu Y
J Cell Biochem; 2018 Sep; 119(9):7599-7609. PubMed ID: 29932248
[TBL] [Abstract][Full Text] [Related]
14. SEMA3G, downregulated by ncRNAs, correlates with favorable prognosis and tumor immune infiltration in kidney renal clear cell carcinoma.
Yuan J; Yuan G
Aging (Albany NY); 2023 Dec; 15(23):13944-13960. PubMed ID: 38070142
[TBL] [Abstract][Full Text] [Related]
15. LncRNA ITGB2-AS1 promotes the progression of clear cell renal cell carcinoma by modulating miR-328-5p/HMGA1 axis.
Zhang W; Lu Y; Shi H; Li X; Zhang Z; Deng X; Yang Y; Wan B
Hum Cell; 2021 Sep; 34(5):1545-1557. PubMed ID: 34170494
[TBL] [Abstract][Full Text] [Related]
16. [Comprehensive analysis of the aberrantly expressed profiles of lncRNAs, miRNAs and the regulation network of the associated ceRNAs in clear cell renal cell carcinoma].
Hou W; Tang Q; Bi F
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2019 Apr; 36(2):267-273. PubMed ID: 31016944
[TBL] [Abstract][Full Text] [Related]
17. Identification of a competing endogenous RNA network related to immune signature in clear cell renal cell carcinoma.
Zhang Y; Dai J; Huang W; Chen Q; Chen W; He Q; Chen F; Zhang P
Aging (Albany NY); 2021 Dec; 13(24):25980-26002. PubMed ID: 34958632
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA ARAP1-AS1 contributes to cell proliferation and migration in clear cell renal cell carcinoma via the miR-361-3p/placental growth factor axis.
Zhong L; Zhong X
Bioengineered; 2021 Dec; 12(1):6629-6642. PubMed ID: 34516333
[TBL] [Abstract][Full Text] [Related]
19. NUF2 is correlated with a poor prognosis and immune infiltration in clear cell renal cell carcinoma.
Zheng B; Wang S; Yuan X; Zhang J; Shen Z; Ge C
BMC Urol; 2023 May; 23(1):82. PubMed ID: 37138262
[TBL] [Abstract][Full Text] [Related]
20. Noncoding-RNA mediated high expression of zinc finger protein 268 suppresses clear cell renal cell carcinoma progression by promoting apoptosis and regulating immune cell infiltration.
Wang K; Gu Y; Ni J; Zhang H; Wang Y; Zhang Y; Sun X; Xu T; Mao W; Peng B
Bioengineered; 2022 Apr; 13(4):10467-10481. PubMed ID: 35735115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
